SHANGHAI RIGHTONGENE BIOTECHNOLOGY revenue breakdown overview

SHANGHAI RIGHTONGENE BIOTECHNOLOGY revenue for the last year amounted to 258.00 M CNY, the most of which — 210.41 M CNY — came from its highest performing source at the moment, Self-produced Reagents, the year earlier bringing 182.23 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI RIGHTONGENE BIOTECHNOLOGY 258.21 M CNY, and the year before that — 424.30 M CNY.